Exploring the efficacious subfractions and underlying mechanisms of Herba Siegesbeckiae against myocardial ischemia/reperfusion injury via the UCHL5/NLRP3 pathway

• Päätekijät: Xuefen Wu (Tekijä), Huan Xia (Tekijä), Wanting Li (Tekijä), Jie Chen (Tekijä), Linnan Zhou (Tekijä), Qian Zhang (Tekijä), Hongcai Shang (Tekijä), Guiyang Xia (Tekijä), Xiaohong Wei (Tekijä), Sheng Lin (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Compuscript Ltd, 2024-10-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Herba Siegesbeckiae (HS) has been traditionally used for managing cardio- and cerebro-vascular diseases. Our previous study demonstrated that HS ameliorates myocardial ischemia/reperfusion (I/R) injury. Also, the differentially expressed proteins between HS and I/R groups were shown to be displayed...